Cantor Fitzgerald Maintains a 'Hold' on Intuitive Surgical (ISRG); Raising Numbers, But Not Looking To Chase Shares
Get Alerts ISRG Hot Sheet
Price: $399.09 -0.25%
Rating Summary:
27 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
27 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald maintains a 'Hold' on Intuitive Surgical (NASDAQ: ISRG) price target of $475.00.
Analyst, Jeremy Feffer, said, "Intuitive put up yet another stellar quarter, beating on both the top and bottom lines as well as on unit sales and procedure growth, while 2012 guidance was raised. Because of these results, we are taking our numbers up and raising our price target from $460 to $475, but the stock remains overvalued, in our view, despite its growth profile. We would prefer not to chase the stock here."
Raises FY12 EPS estimate from $14.34 to $14.62 and FY13 from $16.21 to $16.79.
For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.
Shares of Intuitive Surgical closed at $545.53 yesterday.
Analyst, Jeremy Feffer, said, "Intuitive put up yet another stellar quarter, beating on both the top and bottom lines as well as on unit sales and procedure growth, while 2012 guidance was raised. Because of these results, we are taking our numbers up and raising our price target from $460 to $475, but the stock remains overvalued, in our view, despite its growth profile. We would prefer not to chase the stock here."
Raises FY12 EPS estimate from $14.34 to $14.62 and FY13 from $16.21 to $16.79.
For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.
Shares of Intuitive Surgical closed at $545.53 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Safran SA (SAF:FP) (SAFRY) PT Raised to EUR211 at Citi, 'remain positive on the aftermarket'
- Vertiv Holdings Co. (VRT) PT Raised to $94 at Wolfe Research, 'price targets could continue to trend towards bull case scenarios'
- 4D Molecular Therapeutics (FDMT) PT Lowered to $63 at BMO Capital, 'uncertainty remains a lingering overhang until the PhIII readout'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!